Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2007

01-07-2007 | Original Article

The Influence of Default Options on the Expression of End-of-Life Treatment Preferences in Advance Directives

Authors: Laura M. Kressel, BA, Gretchen B. Chapman, PhD, Elaine Leventhal, MD, PhD

Published in: Journal of General Internal Medicine | Issue 7/2007

Login to get access

Abstract

Background

Advance directives promise to preserve patient autonomy, but research indicates that end-of-life preferences can be influenced by the way in which questions are posed.

Objective

To determine whether preferences expressed by geriatric patients on advance directives are influenced by the default response inherent in the question.

Design

Mailed survey containing 1 of 3 versions of an advance directive.

Setting

General internal medicine outpatient medical practice.

Participants

Outpatients aged 65 or older (n = 106, response rate = 27%).

Interventions

In the “withhold” version of the survey, participants indicated situations where they would want treatments withheld (i.e., the default preference was in favor of treatment). In the “provide” version, participants indicated situations where they would want treatment provided (i.e., the default preference was against treatment). In the forced-choice control version, participants made an explicit decision to withhold or provide treatment for each situation.

Main Outcome Measure

Participants’ treatment preferences.

Results

Preferences differed by condition, F(2, 103) = 3.61, MSE = 0.09, η 2 = .07, p = .03. Participants tended to express the default preference, and thus, were more likely to favor treatment in the “withhold” condition than in the “provide” condition. Preferences in the forced-choice control condition were intermediate.

Conclusions

The default inherent in a question can impact preferences for medical treatment. This default effect limits the utility of advance directives.
Literature
1.
go back to reference Ditto PH, Hawkins NA. Advance directives and cancer decision making near the end of life. Health Psychol. 2005;24(4):S63–S70.PubMed Ditto PH, Hawkins NA. Advance directives and cancer decision making near the end of life. Health Psychol. 2005;24(4):S63–S70.PubMed
2.
go back to reference Fagerlin A, Schneider CE. Enough: the failure of the living will. Hastings Cent Rep. 2004;34(2):30–42.PubMed Fagerlin A, Schneider CE. Enough: the failure of the living will. Hastings Cent Rep. 2004;34(2):30–42.PubMed
3.
go back to reference Ditto PH, Danks JH, Smucker WD, et al. Advance directives as acts of communication. Arch Intern Med. 2001;161(3):421–30.PubMed Ditto PH, Danks JH, Smucker WD, et al. Advance directives as acts of communication. Arch Intern Med. 2001;161(3):421–30.PubMed
4.
go back to reference Coppola KM, Ditto PH, Danks JH, et al. Accuracy of primary care and hospital-based physicians’ predictions of elderly outpatients’ treatment preferences with and without advance directives. Arch Intern Med. 2001;161(3):431–40.PubMed Coppola KM, Ditto PH, Danks JH, et al. Accuracy of primary care and hospital-based physicians’ predictions of elderly outpatients’ treatment preferences with and without advance directives. Arch Intern Med. 2001;161(3):431–40.PubMed
5.
go back to reference Johnson EJ, Goldstein D. Do defaults save lives? Science. 2003;302(5649):1338–9.PubMed Johnson EJ, Goldstein D. Do defaults save lives? Science. 2003;302(5649):1338–9.PubMed
6.
go back to reference Johnson EJ, Steffel M, Goldstein D. Making better decisions: from measuring to constructing preferences. Health Psychol. 2005;24(4):S17–S22.PubMed Johnson EJ, Steffel M, Goldstein D. Making better decisions: from measuring to constructing preferences. Health Psychol. 2005;24(4):S17–S22.PubMed
7.
go back to reference Redelmeier DA, Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA. 1995;273(4):302–5.PubMed Redelmeier DA, Shafir E. Medical decision making in situations that offer multiple alternatives. JAMA. 1995;273(4):302–5.PubMed
8.
go back to reference Payne JW, Bettman JR, Johnson EJ. The Adaptive Decision Maker. New York, NY: Cambridge University Press; 1993. Payne JW, Bettman JR, Johnson EJ. The Adaptive Decision Maker. New York, NY: Cambridge University Press; 1993.
9.
go back to reference Kressel LM, Chapman GB. Default effects in end of life treatment preferences. Med Decis Making. In press. Kressel LM, Chapman GB. Default effects in end of life treatment preferences. Med Decis Making. In press.
10.
go back to reference Madrian BC, Shea DF. The power of suggestion: Inertia in 401(k) participation and savings behavior. Q J Econ. 2001;116(4):1149–525. Madrian BC, Shea DF. The power of suggestion: Inertia in 401(k) participation and savings behavior. Q J Econ. 2001;116(4):1149–525.
11.
go back to reference Schweitzer M. Disentangling status quo and omission effects: an experimental analysis. Org Behav Human Decis Process. 1994;58:457–76. Schweitzer M. Disentangling status quo and omission effects: an experimental analysis. Org Behav Human Decis Process. 1994;58:457–76.
12.
go back to reference McKenzie CR, Liersch MJ, Finkelstein SR. Recommendations implicit in policy defaults. Psychol Sci. 2006;17(5):414–20.PubMed McKenzie CR, Liersch MJ, Finkelstein SR. Recommendations implicit in policy defaults. Psychol Sci. 2006;17(5):414–20.PubMed
Metadata
Title
The Influence of Default Options on the Expression of End-of-Life Treatment Preferences in Advance Directives
Authors
Laura M. Kressel, BA
Gretchen B. Chapman, PhD
Elaine Leventhal, MD, PhD
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0204-6

Other articles of this Issue 7/2007

Journal of General Internal Medicine 7/2007 Go to the issue

Case Reports/Clinical Vignettes

An Unusual Case of Cardiac Amyloidosis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.